Biomolecular surface engineering of pancreatic islets with Thrombomodulin

Acta Biomaterialia

Volumn 6, Issue 6, 2010, Pages 1895-1903

  Wilson, John T ^a,b   Haller, Carolyn A ^b   Qu, Zheng ^b   Cui, Wanxing ^b   Urlam, Murali K ^b   Chaikof, Elliot L ^a,b,c  

^a Emory University   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Georgia Institute of Technology   (United States)

Author keywords

Cell surface engineering; Islet transplantation; Staudinger ligation; Thrombomodulin

Indexed keywords

CATALYST ACTIVITY; CELL MEMBRANES; COENZYMES; GLYCOPROTEINS;

ACTIVATED PROTEIN C; BIOMOLECULAR SURFACE; BIOTINYLATIONS; CELL SURFACE ENGINEERING; ISLET TRANSPLANTATION; PANCREATIC ISLET; STAUDINGER LIGATION; SURFACE ENGINEERING; THROMBOMODULIN; TYPE 1 DIABETES;

CELL ENGINEERING;

ACTIVATED PROTEIN C; ALDEHYDE; AMINE; AZIDE; BIOTIN; STREPTAVIDIN; THROMBOMODULIN; BIOMATERIAL;

ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CATALYSIS; CELL SURFACE; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; STAUDINGER REACTION; TISSUE ENGINEERING; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; MATERIALS TESTING; METHODOLOGY; PHYSIOLOGY; SURFACE PROPERTY;

MURINAE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; ISLETS OF LANGERHANS; MALE; MATERIALS TESTING; MICE; MICE, INBRED C57BL; SURFACE PROPERTIES; THROMBOMODULIN; TISSUE ENGINEERING;

EID: 77956623971     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.01.027     Document Type: Article

References (62)

1. Robertson RP. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004;350:694-705.
2. Shapiro AM et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8.
3. Ricordi C. Islet transplantation: a brave new world. Diabetes 2003;52:1595-603.
4. Mattsson G, Jansson L, Nordin A, Andersson A, Carlsson PO. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes 2004;53:948-54.
5. Ryan EA et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710-9.
6. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 2002;51:66-72.
7. Froud T et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005;5:2037-46.
8. Korsgren O et al. Current status of clinical islet transplantation. Transplantation 2005;79:1289-93.
9. Shapiro AMJ, Nanji SA, Lakey JRT. Clinical islet transplant: current and future directions towards tolerance. Immunol Rev 2003;196:219-36.
10. Frank A et al. Transplantation for type 1 diabetes - comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg 2004;240:631-40.
11. Contreras JL et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 2004;53:2804-14.
12. Yasunami Y et al. Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J Exp Med 2005;202:913-8.
13. Montolio M, Tellez N, Soler J, Montanya E. Role of blood glucose in cytokine gene expression in early syngeneic islet transplantation. Cell Transplant 2007;16:517-25.
14. Bottino R, Fernandez LA, Ricordi C, Lehmann R, Tsan MF, Oliver R, et al. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998;47:316-23.
15. Satoh M et al. Successful islet transplantation to two recipients from a single donor by targeting proinflammatory cytokines in mice. Transplantation 2007;83:1085-92.
16. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998;55:1139-49.
17. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005;77:587-97.
18. Ziats NP, Miller KM, Anderson JM. In vitro and in vivo interactions of cells with biomaterials. Biomaterials 1988;9:5-13.
19. Bennet W et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999;48:1907-14.
20. Moberg L et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002;360:2039-45.
21. Johansson H et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005;54:1755-62.
22. Rabiet MJ, Plantier JL, Dejana E. Thrombin-induced endothelial cell dysfunction. Br Med Bull 1994;50:936-45.
23. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-64.
24. Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004;25:536-42.
25. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet- neutrophilinteractions: linking hemostasis and inflammation. Blood Rev 2007;21:99-111.
26. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378-84.
27. Linn T, Schmitz J, Hauck-Schmalenberger I, Lai Y, Bretzel RG, Brandhorst H, et al. Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clin Exp Immunol 2006;144:179-87.
28. Lukinius A, Jansson L, Korsgren O. Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol 1995;146:429-35.
29. Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas 2004;47:305-14.
30. Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system-integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 2004;24:1374-83.
31. Grey ST, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW. Selective inhibitory effects of the anticoagulant activated protein-C on the responses of human mononuclear phagocytes to Lps, Ifn-gamma, or phorbol ester. J Immunol 1994;153:3664-72.
32. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, et al. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996;87:642-7.
33. Hancock WW, Bach FH. Immunobiology and therapeutic applications of protein C protein S thrombomodulin in human and experimental allotransplantation and xenotransplantation. Trends Cardiovasc Med 1997;7:174-83.
34. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001;276:11199-203.
35. Grinnell BW, Hermann RB, Yan SB. Human protein C inhibits selectinmediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 1994;4:221-5.
36. Cui W, Wilson JT, Wen J, Angsana J, Qu Z, Haller CA, et al. Thrombomodulin improves early outcomes after intraportal islet transplantation. Am J Transplant 2009;9:1308-16.
37. Berg DT et al. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc Natl Acad Sci USA 2003;100:4423-8.
38. Tseng PY, Jordan SW, Sun XL, Chaikof EL. Catalytic efficiency of a thrombomodulin-functionalized membrane-mimetic film in a flow model. Biomaterials 2006;27:2768-75.
39. Sperling C, Salchert K, Streller U, Werner C. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro. Biomaterials 2004;25:5101-13.
40. Badet L, Titus TT, McShane P, Chang LW, Song ZS, Ferguson DJP, et al. Transplantation of mouse pancreatic islets into primates - in vivo and in vitro evaluation. Transplantation 2001;72:1867-74.
41. Cazalis CS, Haller CA, Sease-Cargo L, Chaikof EL. C-terminal site specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity. Bioconjug Chem 2004;15:1005-9.
42. Hsiao SC, Crow AK, Lam WA, Bertozzi CR, Fletcher DA, Francis MB. DNA-coated AFM cantilevers for the investigation of cell adhesion and the patterning of live cells. Angew Chem Int Ed 2008;47:8473-7.
43. Saxon E, Armstrong JI, Bertozzi CR. A "traceless" Staudinger ligation for the chemoselective synthesis of amide bonds. Org Lett 2000;2:2141-3.
44. Wilson JT, Cui W, Chaikof EL. Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett 2008;8:1940-8.
45. Galvin JB, Kurosawa S, Moore K, Esmon CT, Esmon NL. Reconstitution of rabbit thrombomodulin into phospholipid-vesicles. J Biol Chem 1987;262:2199-205.
46. Parkinson JF, Nagashima M, Kuhn I, Leonard J, Morser J. Structure-function studies of the epidermal growth-factor domains of human thrombomodulin. Biochem Biophys Res Commun 1992;185:567-76.
47. Kiick KL, Saxon E, Tirrell DA, Bertozzi CR. Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation. Proc Natl Acad Sci USA 2002;99:19-24.
48. Saxon E, Bertozzi CR. Cell surface engineering by a modified Staudinger reaction. Science 2000;287:2007-10.
49. Cabric S et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 2007;56:2008-15.
50. Yolcu ES, Askenasy N, Singh NP, Cherradi SE, Shirwan H. Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. Immunity 2002;17:795-808.
51. Contreras JL et al. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. Surgery 2004;136:537-47.
52. Lee DY, Park SJ, Lee S, Nam JH, Byun Y. Highly poly (ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication. Tissue Eng 2007;13:2133-41.
53. De Bank PA, Kellam B, Kendall DA, Shakesheff KM. Surface engineering of living myoblasts via selective periodate oxidation. Biotechnol Bioeng 2003;81:800-8.
54. Lemieux GA, Bertozzi CR. Chemoselective ligation reactions with proteins, oligosaccharides and cells. Trends Biotechnol 1998;16:506-13.
55. Sinclair J, Salem AK. Rapid localized cell trapping on biodegradable polymers using cell surface derivatization and microfluidic networking. Biomaterials 2006;27:2090-4.
56. Nishizawa N, Nishimura J, Saitoh H, Fujiki K, Tsubokawa N. Grafting of branched polymers onto nano-sized silica surface. postgrafting of polymers with pendant isocyanate groups of polymer chain grafted onto nano-sized silica surface. Prog Org Coat 2005;53:306-11.
57. Iino S, Abeyama K, Kawahara KI, Aikou T, Maruyama I. Thrombomodulin expression on Langerhans' islet: can endogenous 'anticoagulant on demand' overcome detrimental thrombotic complications in clinical islet transplantation? J Thromb Haemost 2004;2:833-4.
58. Stabler CL, Sun XL, Cui W, Wilson JT, Haller CA, Chaikof EL. Surface reengineering of pancreatic islets with recombinant azido-thrombomodulin. Bioconjug Chem 2007;18:1713-5.
59. Kume M et al. Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats - a possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction. J Hepatol 2003;38:9-17.
60. Arai M, Mochida S, Ohno A, Ogata I, Obama H, Maruyama I, et al. Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor. Thromb Res 1995;80:113-23.
61. Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 1992;80:2556-62.
62. Liaw PC et al. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 2004;104:3958-64.